[1]Locationinpatent:schemeortableZhu,Jason;Razler,ThomasM.;Xu,Zhongmin;Conlon,DavidA.;Sortore,EricW.;Fritz,AlanW.;Demerzhan,Roman;Sweeney,JasonT.[OrganicProcessResearchandDevelopment,2011,vol.15,#2,p.438-442]
85977-52-2 | (S)-1,2,3,4-Tetrahydronaphthoic acid | AA008FTN | MFCD07368365
842136-59-8 | N-Methoxy-N-methyl 5-bromo-2-chlorobenzamide | AA008GKI | MFCD11847367
856171-16-9 | 2-Chloro-6-(1-methylethyl)benzothiazole | AA008H6Z | MFCD04971819
83696-90-6 | 5-Methoxyindole-3-butyric acid | AA008IFO | MFCD03839845
81870-64-6 | Dichloro-[3-[2-(chloromethyl)phenyl]propyl]silicon | AA008L7R | MFCD00054824
80708-26-5 | Pyrido[2,3-b]pyrazin-3(4H)-one, 2-chloro-4-methyl- | AA008M2O | MFCD22613716
774-22-1 | N-Ethyl-4-fluoro-2-nitroaniline | AA008MSO | MFCD00798367
77257-42-2 | MG 624 | AA008NGB | MFCD00865233
7699-35-6 | (Z)-3-(3H-imidazol-4-yl)prop-2-enoic acid | AA008O9C | MFCD11045310